Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

CME Group Inc. (CME - Analyst Report) was sued by 24 brokers and traders of the Chicago Board of Trade (“CBOT”) last Friday. This was in protest of its declaration of doing away with the “open-outcry trading pit system” pertaining to agricultural trading and opting for a new process. The change was scheduled to be effective from June 25 after being postponed due to several oppositions since December last year.

The new procedure, as planned by the company, would discard open-outcry with the electronic trading information using a common algorithm. As a result, in anticipation of a negative impact, there was a sharp drop in volumes being traded.

This change may threaten the role of floor traders and many fears that they will lose their job if this change is brought into effect. However, this initiative undertaken by the CME Group is an effort to keep the exchange at par with the requirements of the federal Commodity Exchange Act and Commodity Futures Trading Commission.

If CME Group is found guilty, it would have to compensate for the damages in monetary terms. Further developments are expected to throw more light on the issue as the company continues to confront hurdles for entering the electronic trading platform along with intense competition, which has been affecting both volume and pricing of the exchange.

The company’s closest competitor, Nasdaq OMX Group Inc. (NDAQ - Analyst Report), also faced the wrath of one of the IPO investors, who questioned NASDAQ’s failure to process orders to buy, sell or cancel requests for Facebook Inc.’s (FB - Analyst Report) shares on time, causing them to suffer losses. The investors hope to obtain a class action status for a case filed against the company regarding this. The latter had tried to order and then cancel requests for Facebook shares but was unable to do so, owing to the technical glitch in the trading platform.

CME Group currently retains a Zacks #4 Rank, which translates into a short-term Sell rating. We are also maintaining our long-term Underperform recommendation on the shares.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GRP IN DXYN 15.84 +7.90%
BOFI HLDG IN BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%